Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Molecular Imaging and Biology
Published in: Molecular Imaging and Biology 4/2015

01-08-2015 | Research Article

Quantitative SPECT/CT Imaging of 177Lu with In Vivo Validation in Patients Undergoing Peptide Receptor Radionuclide Therapy

Authors: J. C. Sanders, T. Kuwert, J. Hornegger, P. Ritt

Published in: Molecular Imaging and Biology | Issue 4/2015

Login to get access

Abstract

Purpose

The purpose of this study is to extend an established SPECT/CT quantitation protocol to 177Lu and validate it in vivo using urine samples, thus providing a basis for 3D dosimetry of 177Lu radiotherapy and improvement over current planar methods which improperly account for anatomical variations, attenuation, and overlapping organs.

Procedures

In our quantitation protocol, counts in images reconstructed using an ordered subset-expectation maximization algorithm are converted to kilobecquerels per milliliter using a calibration factor derived from a phantom experiment. While varying reconstruction parameters, we tracked the ratio of image to true activity concentration (recovery coefficient, RC) in hot spheres and a noise measure in a homogeneous region. The optimal parameter set was selected as the point where recovery in the largest three spheres (16, 8, and 4 ml) stagnated, while the noise continued to increase.
Urine samples were collected following 12 SPECT/CT acquisitions of patients undergoing [177Lu]DOTATATE therapy, and activity concentrations were measured in a well counter. Data was reconstructed using parameters chosen in the phantom experiment, and estimated activity concentration from the images was compared to the urine values to derive RCs.

Results

In phantom data, our chosen parameter set yielded RCs in 16, 8, and 4 ml spheres of 80.0, 74.1, and 64.5 %, respectively. For patients, the mean bladder RC was 96.1 ± 13.2 % (range, 80.6–122.4 %), with a 95 % confidence interval between 88.6 and 103.6 %. The mean error of SPECT/CT concentrations was 10.1 ± 8.3 % (range, −19.4–22.4 %).

Conclusions

Our results show that quantitative 177Lu SPECT/CT in vivo is feasible but could benefit from improved reconstruction methods. Quantifying bladder activity is analogous to determining the amount of activity in the kidneys, an important task in dosimetry, and our results provide a useful benchmark for future efforts.
Literature
1.
Stillebroer AB, Boerman OC, Desar IME et al (2013) Phase 1 radioimmunotherapy study with lutetium 177-labeled anti-carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma. Eur Urol 64:478–485PubMedCrossRef
2.
Tagawa ST, Milowsky MI, Morris M et al (2013) Pase II study of lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer. Clin Cancer Res 19:5182–5191PubMedCrossRefPubMedCentral
3.
Chakraborty S, Das T, Banerjee S et al (2006) Preparation and preliminary biological evaluation of 177Lu-labelled hydroxyapatite as a promising agent for radiation synovectomy of small joints. Nucl Med Commun 27:661–668PubMedCrossRef
4.
Krenning EP, Kooij PPM, Bakker WH et al (1994) Radiotherapy with a radiolabeled somatostatin analogue, [111In-DTPA-D-Phe1]-octreotide. Ann N Y Acad Sci 733:496–506PubMedCrossRef
5.
de Jong M, Bakker WH, Breeman WAP et al (1998) Pre-clinical comparison of [DPTA0] octreotide, [DTPA0, Tyr3] octreotide and [DOTA0, Tyr3] octreotide as carriers for somatostatin receptor-targeted scintigraphy and radionuclide therapy. Int J Cancer 75:406–411PubMedCrossRef
6.
Valkema R, Pauwels S, Kvols LK et al (2006) Survival and response after peptide receptor radionuclide therapy with [90Y-DOTA0, Tyr3]octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors. Semin Nucl Med 36:147–156PubMedCrossRef
7.
Forrer F, Valkema R, Kwekkeboom DJ et al (2007) Peptide receptor radionuclide therapy. Best Pract Res Clin Endocrinol Metab 21:111–129PubMedCrossRef
8.
Teunissen JJM, Kwekkeboom DJ, Valkema R et al (2011) Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours. Endocr Relat Cancer 18:S27–S51PubMedCrossRef
9.
Kwekkeboom DJ, Bakker WH, Kooij PP et al (2001) [177Lu-DOTA0, Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients. Eur J Nucl Med Mol Imaging 28:1319–1325CrossRef
10.
de Jong M, Valkema R, Jamar F et al (2002) Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings. Semin Nucl Med 32:133–140PubMedCrossRef
11.
Kwekkeboom DJ, de Herder WW, Kam BL et al (2008) Treatment with the radiolabeled somatostatin analog [177Lu-DOTA0, Tyr3]octreotate: toxicity, efficacy, and survival. J Clin Oncol 28:2124–2130CrossRef
12.
Khan S, Krenning EP, van Essen M et al (2011) Quality of life in 265 patients with gastroenteropancreatic or bronchial neuroendocrine tumors treated with [177Lu-DOTA0, Tyr3]octreotate. J Nucl Med 52:1361–1368PubMedCrossRef
13.
14.
Forrer F, Uusijärvi H, Waldherr C et al (2004) A comparison of 177In-DOTATOC and 111In-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumours. Eur J Nucl Med 31(9):1257–1262CrossRef
15.
Ritt P, Vija H, Hornegger J, Kuwert T (2011) Absolute quantification in SPECT. Eur J Nucl Med Mol Imaging 38:S69–S77PubMedCrossRef
16.
Willowson K, Bailey DL, Baldock C (2008) Quantitative SPECT reconstruction using CT-derived corrections. Phys Med Biol 53:3099–3112PubMedCrossRef
17.
Bailey DL, Willowson KP (2014) Quantitative SPECT/CT: SPECT joins PET as a quantitative imaging modality. Eur J Nucl Med Mol Imaging 41:S17–S25PubMedCrossRef
18.
Sandström M, Garske U, Granberg D et al (2010) Individualized dosimetry in patients undergoing therapy with 177Lu-DOTA-D-Phe1-Tyr3-octreotate. Eur J Nucl Med Mol Imaging 37:212–225PubMedCrossRef
19.
Ichihara T, Ogawa K, Motomura N et al (1993) Compton scatter compensation using the triple-energy window method for single- and dual-isotope SPECT. J Nucl Med 34:2216–2221PubMed
20.
de Nijs R, Lagerburg V, Klausen TL, Holm S (2014) Improving quantitative dosimetry in 177Lu-DOTATATE SPECT by energy window-based scatter corrections. Nucl Med Commun 35:522–533PubMedCrossRefPubMedCentral
21.
Vija AH, Hawman EG, Engdahl JC (2003) Analysis of a SPECT OSEM reconstruction method with 3D beam modeling and optional attenuation correction: phantom studies. IEEE Nucl Sci Symp Med Imaging Conf Rec 4:2662–2666
22.
Zeintl J, Vija AH, Yahil A et al (2010) Quantitative accuracy of clinical 99mTc SPECT/CT using ordered-subset expectation maximization with 3-dimensional resolution recovery, attenuation, and scatter correction. J Nucl Med 51:921–928PubMedCrossRef
23.
Beauregard J-M, Hofman MS, Pereira JM et al (2011) Quantitative 177Lu SPECT (QSPECT) imaging using a commercially available SPECT/CT system. Cancer Imaging 11:56–66PubMedCrossRefPubMedCentral
24.
Hudson HM, Larkin RS (1994) Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imaging 13:601–609PubMedCrossRef
25.
Dewaraja YK, Frey EC, Sgouros G et al (2012) MIRD Pamphlet no. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy. J Nucl Med 53:1310–1325PubMedCrossRefPubMedCentral
26.
Chun SY, Fessler JA, Dewaraja YK (2013) Post-reconstruction non-local means filtering methods using CT side information for quantitative SPECT. Phys Med Biol 58:6225–6240PubMedCrossRef
27.
Tsui BMW, Zhao XD, Frey EC (1991) Comparison between ML-EM and WLS-CG algorithms for SPECT image reconstruction. IEEE Trans Nucl Sci 38:1766–1772CrossRef
28.
Schötzig U, Schrader H, Schönfeld E et al (2001) Standardisation and decay data of 177Lu and 188Re. Appl Radiat Isot 55:89–96PubMedCrossRef
29.
Hutton BF, Hudson HM, Beekman FJ (1997) A clinical perspective of accelerated statistical reconstruction. Eur J Nucl Med Mol Imaging 24:797–808
30.
Shcherbinin S, Piwowarska-Bilska H, Celler A, Birkenfeld B (2012) Quantitative SPECT/CT reconstruction for 177Lu and 177Lu/90Y targeted radionuclide therapies. Phys Med Biol 57:5733–5747PubMedCrossRef
31.
Sorenson JA (1975) Deadtime characteristics of Anger cameras. J Nucl Med 16:284–288PubMed
32.
Frey EC, Tsui BMW (1996) A new method for modeling the spatially-variant, object-dependent scatter response function in SPECT. IEEE Nucl Sci Symp Med Imaging Conf Rec 2:1082–1086
33.
Fessler JA, Rogers WL (1996) Spatial resolution properties of penalized-likelihood image reconstruction: space-invariant tomographs. IEEE Trans Image Proc 5:1346–1358CrossRef
34.
Liow JS, Strother SC (1993) The convergence of object dependent resolution in maximum likelihood based tomographic image reconstruction. Phys Med Biol 38:55–70PubMedCrossRef
35.
Maus J, Hofheinz F, Schramm G et al (2014) Evaluation of PET quantification accuracy in vivo. Nuklearmedizin 53:67–77PubMedCrossRef
Metadata
Title
Quantitative SPECT/CT Imaging of 177Lu with In Vivo Validation in Patients Undergoing Peptide Receptor Radionuclide Therapy
Authors
J. C. Sanders
T. Kuwert
J. Hornegger
P. Ritt
Publication date
01-08-2015
Publisher
Springer US
Published in
Molecular Imaging and Biology / Issue 4/2015
Print ISSN: 1536-1632
Electronic ISSN: 1860-2002
DOI
https://doi.org/10.1007/s11307-014-0806-4

Other articles of this Issue 4/2015

Molecular Imaging and Biology 4/2015 Go to the issue

Research Article

Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [18F]UCB-H: First-in-Human Study

Research Article

Comparison of [18F]DCFPyL and [68Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer

Brief Article

Molecular Imaging of PDE10A Knockout Mice with a Novel PET Radiotracer: [11C]T-773

Research Article

Evaluation of Functionalized Polysaccharide Microparticles Dosimetry for SPECT Imaging Based on Biodistribution Data of Rats

Research Article

Assessing Amide Proton Transfer (APT) MRI Contrast Origins in 9 L Gliosarcoma in the Rat Brain Using Proteomic Analysis

Research Article

Correlation between Choline Peak at MR Spectroscopy and Calcium-Sensing Receptor Expression Level in Breast Cancer: A Preliminary Clinical Study